These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 21437998)

  • 1. Allowable Total Error and Limits for Erroneous Results (ATE/LER) zones for agreement measurement.
    Zhou YH; Zang JJ; Wu MJ; Xu JF; He J
    J Clin Lab Anal; 2011; 25(2):83-9. PubMed ID: 21437998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measuring Analytical Quality: Total Analytical Error Versus Measurement Uncertainty.
    Westgard JO; Westgard SA
    Clin Lab Med; 2017 Mar; 37(1):1-13. PubMed ID: 28153359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Standardization of the laboratory test for PSA].
    Kwiatkowski M; Recker F; Huber A; Sergeeva NA; Brinkmann T
    Urologiia; 2010; (4):64, 66-7. PubMed ID: 20967984
    [No Abstract]   [Full Text] [Related]  

  • 4. [Allowable limits of analytical error which can guarantee the reliability of reference intervals for interpretation of clinical laboratory data].
    Hosogaya S; Ozaki Y
    Rinsho Byori; 2008 Jul; 56(7):617-21. PubMed ID: 18709995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding Bland Altman analysis.
    Giavarina D
    Biochem Med (Zagreb); 2015; 25(2):141-51. PubMed ID: 26110027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate cancer screening: clinical impact of WHO calibration of Beckman Coulter Access prostate-specific antigen assays.
    Fillée C; Tombal B; Philippe M
    Clin Chem Lab Med; 2010 Feb; 48(2):285-8. PubMed ID: 20001849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single small focus of prostate adenocarcinoma (< or = 1 mm and too small for grading) and clinical significant disease after radical prostatectomy.
    Taverna G; Colombo P; Seveso M; Giusti G; Piccinelli A; Benetti A; Graziotti P
    Arch Ital Urol Androl; 2006 Jun; 78(2):57-60. PubMed ID: 16929604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laboratory methods cause ultrasensitive prostate-specific antigen fluctuations.
    Okullo A; Penkoff P; Patel MI
    ANZ J Surg; 2017 Sep; 87(9):651-652. PubMed ID: 28876540
    [No Abstract]   [Full Text] [Related]  

  • 9. Prostate-specific antigen: a clinical and mathematical conundrum.
    Swanson KR; Harpold HL; True LD
    Am J Clin Pathol; 2006 Mar; 125(3):331-3. PubMed ID: 16613335
    [No Abstract]   [Full Text] [Related]  

  • 10. Discordant total and free prostate-specific antigen (PSA) assays: does calibration with WHO reference materials diminish the problem?
    Stephan C; Köpke T; Semjonow A; Lein M; Deger S; Schrader M; Miller K; Jung K
    Clin Chem Lab Med; 2009; 47(11):1325-31. PubMed ID: 19778292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparability of serum prostate-specific antigen measurement between the Roche Diagnostics Elecsys 2010 and the Abbott Architect i2000.
    Gray MA; Cooke RR; Weinstein P; Nacey JN
    Ann Clin Biochem; 2004 May; 41(Pt 3):207-12. PubMed ID: 15117434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A quantitative model for the dynamics of serum prostate-specific antigen as a marker for cancerous growth: an explanation for a medical anomaly.
    Swanson KR; True LD; Lin DW; Buhler KR; Vessella R; Murray JD
    Am J Pathol; 2001 Jun; 158(6):2195-9. PubMed ID: 11395397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnostic value of tissue and serum prostate specific antigen in prostate cancer].
    Medvedev VL
    Voen Med Zh; 2004 Feb; 325(2):50-4. PubMed ID: 15101295
    [No Abstract]   [Full Text] [Related]  

  • 14. [Incidental prostatic adenocarcinoma in the ere of the PSA].
    Picurelli Oltra L; Sendra Torres A; Fernández Rodríguez A; Ortega Villar F; Baixauli Martínez J; Tramoyeres Celma A
    Actas Urol Esp; 1997 Apr; 21(4):354-6. PubMed ID: 9265406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PSA measurement following prostatectomy: an unexpected error.
    Descotes JL; Legeais D; Gauchez AS; Long JA; Rambeaud JJ
    Anticancer Res; 2007; 27(2):1149-50. PubMed ID: 17465255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining allowable total error limits in the clinical laboratory.
    Palmer J; Galior K
    Adv Clin Chem; 2024; 118():205-223. PubMed ID: 38280806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Current results on PSA-based prostate cancer detection].
    Graefen M; Schlomm T; Steuber T; Sauter G
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Mar; 57(3):312-7. PubMed ID: 24562706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mostly for men.
    Isaacson RJ
    Angle Orthod; 2005 Jul; 75(4):694. PubMed ID: 16097243
    [No Abstract]   [Full Text] [Related]  

  • 19. Prostate detection possibility.
    Gunby P
    JAMA; 1999 Jun 23-30; 281(24):2274-5. PubMed ID: 10386541
    [No Abstract]   [Full Text] [Related]  

  • 20. Extremely high PSA (250ng/ml) in a patient with localised prostatic carcinoma.
    Colgan G; O'Brien MF; Ahmad I; Thornhill JA
    Ir Med J; 2005 Jan; 98(1):29. PubMed ID: 15782735
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.